(Q51669080)

English

The relation of clinical symptoms and anti-ganglioside antibodies to MEPPs frequency increase in 8 cases of variant type Guillain-Barré syndrome.

scientific article published in June 2003

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/12795712

The relation of clinical symptoms and anti-ganglioside antibodies to MEPPs frequency increase in 8 cases of variant type Guillain-Barré syndrome. (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/12795712

Guillain–Barré syndrome

0 references

author name string

Masahiko Kishi

1

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/12795712

Toshiki Fujioka

2

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/12795712

Hiroko Miura

3

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/12795712

Akiko Sekine

4

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/12795712

Hiroaki Iguchi

5

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/12795712

Hiroshi Nakazora

6

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/12795712

Tetuhito Kiyozuka

7

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/12795712

Osamu Igarashi

8

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/12795712

Yasumitu Ichikawa

9

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/12795712

Hideki Sugimoto

10

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/12795712

Teruyuki Kurihara

11

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/12795712

Sachiko Irie

12

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/12795712

Toyokazu Saito

13

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/12795712

publication date

1 June 2003

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/12795712

Journal of the Peripheral Nervous System

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/12795712

8

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/12795712

2

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/12795712

82-90

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/12795712

Immunoglobulin G from a patient with Miller-Fisher syndrome rapidly and reversibly depresses evoked quantal release at the neuromuscular junction of mice.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1529-8027.2003.03011.X

21 January 2018

Ganglioside composition of the human cranial nerves, with special reference to pathophysiology of Miller Fisher syndrome

1 reference

https://api.crossref.org/works/10.1046%2FJ.1529-8027.2003.03011.X

21 January 2018

Guillain-Barré syndrome serum and anti-Campylobacter antibody do not exacerbate experimental autoimmune neuritis.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1529-8027.2003.03011.X

21 January 2018

Pathogenesis of Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1046%2FJ.1529-8027.2003.03011.X

21 January 2018

Detection and prevalence of alpha-latrotoxin-like effects of serum from patients with Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1046%2FJ.1529-8027.2003.03011.X

21 January 2018

Anti-GQ1b ganglioside antibodies mediate complement-dependent destruction of the motor nerve terminal

1 reference

https://api.crossref.org/works/10.1046%2FJ.1529-8027.2003.03011.X

21 January 2018

The clinical and laboratory features of chronic sensory ataxic neuropathy with anti-disialosyl IgM antibodies

1 reference

https://api.crossref.org/works/10.1046%2FJ.1529-8027.2003.03011.X

21 January 2018

Acute ophthalmoparesis (without ataxia) associated with anti-GQ1b IgG antibody: clinical features

1 reference

https://api.crossref.org/works/10.1046%2FJ.1529-8027.2003.03011.X

21 January 2018

Animal model of axonal Guillain-Barré syndrome induced by sensitization with GM1 ganglioside

1 reference

https://api.crossref.org/works/10.1046%2FJ.1529-8027.2003.03011.X

21 January 2018

Chemokine mRNA expression in the cauda equina of Lewis rats with experimental allergic neuritis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1529-8027.2003.03011.X

21 January 2018

Association of anti-GM2 antibodies in Guillain-Barré syndrome with acute cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1046%2FJ.1529-8027.2003.03011.X

21 January 2018

Miller Fisher anti-GQ1b antibodies: alpha-latrotoxin-like effects on motor end plates

1 reference

https://api.crossref.org/works/10.1046%2FJ.1529-8027.2003.03011.X

21 January 2018

Fisher syndrome with tetraparesis and antibody to GQ1b: evidence for motor nerve terminal block

1 reference

https://api.crossref.org/works/10.1046%2FJ.1529-8027.2003.03011.X

21 January 2018

Prominent sensory ataxia in Guillain-Barré syndrome associated with IgG anti-GD1b antibody

1 reference

https://api.crossref.org/works/10.1046%2FJ.1529-8027.2003.03011.X

21 January 2018

Identifiers

10.1046/J.1529-8027.2003.03011.X

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/12795712

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/12795712

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51669080&oldid=2155917565"